This document written by the BioPhorum Lab of the Future team explains the benefits of progressively more sophisticated lab instrument integration. It explains why better integration is needed, how to think of it in stages, and how to use it to bring about changes...
The biomanufacturing industry faces unprecedented challenges in meeting demand, reducing costs, and increasing manufacturing quality across current drug portfolios. In addition, new classes of biological medicines are being developed that require a radical shift in...
The Danish Medicines Agency (DKMA) is working to define criteria for the application of artificial intelligence (AI) and machine learning (ML) across GxP-regulated areas.  To understand the biopharmaceutical industry’s position, it has been gathering information using...
